Tayt Ellison, MD
Orthopaedic Surgery · Minneapolis, MNNPI 1194185231
Payments from drug & device makers
Across 71 payments — averaging $322.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$10K
- CGG Medical Inc$4K
- Stryker$4K
- Medinc Of Texas$3K
- Arthrex$615
- Vericel Corporation$205
- plus $789 from 12 others
What the payments were for
- Speaking & faculty fees$970%
- Grants$10,00044%
- Travel & lodging$2,38710%
- Food & beverage$2,92013%
- Education$7,46833%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smith+Nephew | 5 | $10,297 |
| CGG Medical Inc | 10 | $3,947 |
| Stryker(2 entities) | 25 | $3,531 |
| Medinc Of Texas | 4 | $3,487 |
| Arthrex | 9 | $615 |
| Vericel Corporation | 4 | $205 |
| Skeletal Dynamics Inc | 2 | $193 |
| Zimmer Biomet | 1 | $181 |
| Terumo BCT, Inc. | 1 | $125 |
| Acumed LLC | 1 | $97 |
| Foundation Medical, LLC | 1 | $56 |
| Misonix Inc | 1 | $33 |
| AbbVie(2 entities) | 2 | $24 |
| Ossur Americas, Inc. | 1 | $21 |
| Paratek Pharmaceuticals, Inc. | 1 | $20 |
| Orthalign Inc | 1 | $15 |
| Pacira Pharmaceuticals Incorporated | 1 | $14 |
| Orthofix Medical, Inc. | 1 | $9 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PRO$2,235
- PANGEA$275
- GAMMA$160
- Bioinductive Implant with Arthroscopic Delivery System - Medium$149
- MACI$138
- NONE$129
- Bone Marrow Aspirate Concentrate System$125
- SIMPLICITI$125
- T2$112
How this compares
$22,872 in reported general payments places this provider in the 75th percentile of 533 orthopaedic surgery providers in Minnesota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other orthopaedic surgery in Minneapolis
- David PollyMinneapolis$3.4M
- Ensor TransfeldtMinneapolis$2.3M
- Manuel PintoMinneapolis$1.7M
- Joseph PerraMinneapolis$1.6M
- Timothy GarveyMinneapolis$1.6M
- Amir MehbodMinneapolis$1.3M
- David TemplemanMinneapolis$361K
- Jonathan SembranoMinneapolis$352K
- Christopher MartinMinneapolis$276K
- Patrick YoonMinneapolis$203K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.